ANGLE plc (LON:AGL)‘s stock had its “corporate” rating reissued by stock analysts at FinnCap in a report released on Monday. They currently have a GBX 100 ($1.29) price objective on the stock. FinnCap’s price target would indicate a potential upside of 198.51% from the stock’s previous close.
Separately, Beaufort Securities reiterated a “speculative buy” rating on shares of ANGLE plc in a report on Wednesday, July 5th.
ANGLE plc (LON AGL) opened at 33.50 on Monday. The company’s market capitalization is GBX 24.57 million. ANGLE plc has a 52 week low of GBX 32.27 and a 52 week high of GBX 80.00. The company has a 50 day moving average price of GBX 41.24 and a 200-day moving average price of GBX 50.72.
ILLEGAL ACTIVITY WARNING: This article was reported by Markets Daily and is the property of of Markets Daily. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://www.themarketsdaily.com/2017/09/13/angle-plc-agl-stock-rating-reaffirmed-by-finncap.html.
About ANGLE plc
ANGLE plc is a holding company. The Company’s principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health.
Receive News & Ratings for ANGLE plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE plc and related companies with MarketBeat.com's FREE daily email newsletter.